Jesse Siffledeen
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Nationalization of clinical care pathways for inflammatory bowel disease management in Canada.
Journal: Journal of the Canadian Association of Gastroenterology
Published: August 05, 2026
Cendakimab in Adults and Adolescents with Eosinophilic Esophagitis.
Journal: NEJM evidence
Published: September 23, 2025
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study.
Journal: United European gastroenterology journal
Published: March 24, 2025
Treatment patterns for advanced therapies in Canadians with moderate-to-severe inflammatory bowel disease: a retrospective cohort analysis.
Journal: Journal of the Canadian Association of Gastroenterology
Published: February 05, 2025
Long-Term Effectiveness and Safety of Ustekinumab Dose Escalation in Patients with Moderate-to-Severe Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
Journal: Digestive diseases and sciences
Published: January 16, 2025
Editorial: Defining corticosteroid use in clinical trials.
Journal: Alimentary pharmacology & therapeutics
Published: September 23, 2024
Disparities in Advanced Therapy Initiation for Inflammatory Bowel Disease: Access Comes First.
Journal: Digestive diseases and sciences
Published: July 02, 2024
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 12, 2024
Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
Journal: Digestive diseases and sciences
Published: December 19, 2023
Exploring Patient Perspectives on a 12-Week Online, Stress Reduction Intervention in Inflammatory Bowel Disease.
Journal: Crohn's & colitis 360
Published: August 04, 2022
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease.
Journal: Therapeutic advances in gastroenterology
Published: April 08, 2022
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Journal: Lancet (London, England)
Published: November 16, 2021
Last Updated: 09/26/2026